Interview: A Dual Inhibitor Approach Shows Promise in Eye Cancer
Preclinical data suggest that a combined approach to metastatic uveal melanoma may be a viable treatment option. According to the findings, the combination of...
Rheum Round-up: Interview—Expert Weighs In on Trump Taking Hydroxychloroquine, Biologics and Cancer, and more
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about President Donald Trump’s recent admission...
Do Biologics Increase Melanoma Risk? Jury May Still Be Out
Patients with inflammatory diseases such as rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) are often placed on biologic therapies for treatment. Questions...
Are Patients Receptive to AI Use for Skin Cancer Screening?
The use of artificial intelligence (AI) in health care is becoming more widespread, but how patients feel about it is a question up for...
Statins May Help Decrease the Risk for Melanoma Recurrence
Patients taking statins prior to receiving a melanoma diagnosis have a decreased risk of a melanoma recurrence compared with those not taking statins, according...
Bereaved Individuals Have a Higher Risk of Dying from Melanoma, but are Less Likely...
Bereaved people who experience the loss of a partner have an increased risk of dying if diagnosed with melanoma, according to the results of...
Social Media Literacy May Help Reduce Your Risk of Skin Cancer
Knowledge and understanding of how social media influences a desire for tanner skin and positive attitudes toward tanning may help lower the risk of...
